AUS
NZ
UK
CA
USA
IND
Healthcare
Ramsay Health Care (ASX: RHC) Sees Soaring Shares on Impressive Half-year Profits
February 29, 2024 05:51 PM AEDT| By Team Kalkine MediaShares of Ramsay Health Care (,ASX: RHC,) have witnessed a remarkable surge ON 29 February 2024, leaping as much as 7.27% to AU$54.91 apiece. Let's delve into the key factors driving this surge and what it means for investors.,Ramsay Health Care's St...
Sonic Healthcare (ASX: SHL) releases half-year results, shares in red
February 20, 2024 06:14 PM AEDT| By Team Kalkine MediaIn a notable market move, Sonic Healthcare Ltd's (,ASX: SHL,) share price experiences a decline of nearly 7.79%, settling at AU$29.24 on 20 February 2024. This downward trend follows the release of the company's half-year results, outlining both chal...
Cochlear's stock price drops despite a 29% dividend increase
February 19, 2024 06:32 PM AEDT| By Team Kalkine MediaCochlear Limited (,ASX: COH,) encountered a downturn in its share price on Monday morning, notwithstanding the unveiling of robust earnings for the six months ending 31 December.,The company's shares closed at $334.54 last week. However, the,ASX heal...
Cochlear Limited (ASX: COH) shares dropped on Monday. Here’s why.
February 19, 2024 05:16 PM AEDT| By Team Kalkine MediaCochlear Limited's (,ASX: COH,) shares experienced a decline on Monday (19 February 2024), despite the release of its latest earnings report covering the six months to 31 December. Let's delve into the key aspects influencing this market movement.,Ea...
CSL (ASX: CSL) shares in red, shares CSL 112 phase 3 trial results
February 12, 2024 04:30 PM AEDT| By Sonal GoyalShares of CSL (,ASX: CSL,) faced a downturn on Monday, as the biotechnology firm's announces that the phase 3 trial for its cardiovascular drug, CSL112, failed to meet its primary efficacy endpoint. Let's delve into the details of this impactful even...
Cochlear (ASX: COH) upgrades FY24 earnings guidance, expects net profit of AU$385-400M
February 08, 2024 01:18 PM AEDT| By Team Kalkine MediaCochlear Ltd (,ASX: COH,), a leader in hearing solutions, has recently made significant announcements, including the upgrade of FY24 earnings guidance. This article delves into the details of these upgrades and their implications.,Cochlear Ltd has ma...
Up over 5%, here's why Cochlear's (ASX: COH) shares surging on Tuesday
February 06, 2024 05:34 PM AEDT| By Team Kalkine MediaThe financial landscape witnessed a tumultuous Tuesday (6 February 2024), with the S&P/ASX 200 Index sliding by 0.58%, causing distress among ASX 200 shares. However, the spotlight remains on Cochlear Limited (,ASX: COH,), an ASX 200 healthcare stock...
CSL (ASX: CSL) shares up 28% since October end
February 05, 2024 06:06 PM AEDT| By Team Kalkine MediaThe recent fluctuations in CSL Ltd's (,ASX: CSL,) shares have captivated the attention of investors and market enthusiasts alike. Despite a 28% surge since the end of October, the biotech giant finds itself in a challenging position, especially in th...
ResMed (ASX: RMD) share rice trading in green on Thursday. Here’s why.
January 25, 2024 03:16 PM AEDT| By Team Kalkine MediaInvestors in ResMed Inc (,ASX: RMD,) are celebrating as the company's share price experiences a robust surge, climbing 6.5% to AU$28.50 on 25 January 2024. The market excitement follows ResMed's outstanding second-quarter results, surpassing expectat...
Why are PolyNovo (ASX: PNV) shares trading in green today?
January 22, 2024 02:52 PM AEDT| By Team Kalkine MediaPolyNovo Limited (,ASX: PNV,), a medical device developer, witnessed a notable upswing as its shares rose by 9.78%, reaching AU$1.740 on 22 January 2024. This marks the highest point for PolyNovo's stock since January 5, sparking interest and specula...
How can GLP-1 drug impact performance of ResMed (ASX: RMD)?
January 18, 2024 07:41 PM AEDT| By Team Kalkine MediaThe ResMed Inc. (,ASX: RMD,) share price has navigated a challenging 12 months, experiencing fluctuations driven by market concerns regarding GLP-1 drugs like Ozempic. As the eagerly anticipated Q2 update approaches, investors are contemplating wheth...
What analysts have to say about CSL (ASX: CSL) shares?
January 18, 2024 07:04 PM AEDT| By Team Kalkine MediaInvestors who witnessed the meteoric rise of CSL Limited (,ASX: CSL,) in the early 2020s might find the recent trajectory perplexing. The company, known for its double-digit share price gains, soared from under AU$100 in 2015 to surpass the AU$300 ma...
A look at ROE and earnings growth of Ansel (ASX: ANN)
January 18, 2024 07:02 PM AEDT| By Team Kalkine MediaIn the dynamic realm of financial markets, Ansell's (,ASX: ANN,) stock has surged considerably over the past three months. Investors are often keen to understand the driving forces behind such price movements, especially when it comes to a company's...
Analysts expects ASX 200 healthcare sector to be affected by cost inflation
January 15, 2024 05:28 PM AEDT| By Team Kalkine MediaIn the dynamic landscape of the Australian healthcare sector, analysts at Morgan Stanley anticipate ongoing challenges for companies, primarily stemming from cost inflation. As the sub-index for Australian healthcare (INDEXASX: XHJ) experiences a 0.4...
Morgan Stanley Downgrades Healius (ASX: HLS) Rating. Here’s Why.
January 12, 2024 04:46 PM AEDT| By Team Kalkine MediaIn the fast-paced world of finance, every market move is closely scrutinized. Recently, the spotlight has fallen on Healius (,ASX: HLS,) as Morgan Stanley downgraded the stock from "Equal-weight" to "Underweight," citing uncertainties surrounding the...
CSL (ASX: CSL) gets limelight in CSL. Here’s why
January 04, 2024 03:22 PM AEDT| By Team Kalkine MediaThe new year brings opportunities for investors to consider new portfolio additions, and CSL Limited (,ASX: CSL,) shares emerge as a highly recommended option.,Overview of Brokers' Positive Ratings on CSL Shares,A substantial number of brokers have i...
Is the Value of CSL Shares Justified at Current Prices?
December 27, 2023 04:32 PM AEDT| By Team Kalkine MediaCSL Limited (,ASX: CSL,) shares have demonstrated a relatively subdued performance over the year, currently reflecting a modest 1% decline in contrast to the ASX 200 index's commendable gain of approximately 8%. Despite this divergence, notable broke...
Can NIB Shares Outperform the Market in 2024?
December 21, 2023 04:37 PM AEDT| By Team Kalkine MediaNIB Holdings Limited (,ASX: NHF,) has experienced a lackluster performance in 2023, with shares losing 4.5% of their value since the beginning of the year. In contrast, the ASX 200 index has shown a positive trend, rising approximately 7% during the...
Why Is This Healthcare Stock Surging 32% on Monday?
December 18, 2023 05:41 PM AEDT| By Team Kalkine MediaFollowing a trading halt, Neuren Pharmaceuticals Ltd (,ASX: NEU,) has made a remarkable return to the market, with shares surging 32% to a record high of $22.70 in morning trade. The catalyst behind this surge is the promising top-line results from t...
ACCC's Verdict: No Green Light for Australian Clinical Labs' (ASX: ACL) Healius Acquisition
December 15, 2023 06:39 PM AEDT| By Team Kalkine MediaIn a significant turn of events, the Australian Competition and Consumer Commission (ACCC) has taken a firm stance against the proposed acquisition of,Healius Ltd (ASX: HLS),by Australian Clinical Labs Limited (,ASX: ACL,).,The regulatory body assert...
Advertise your brand on Kalkine Media